IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

Go back to IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
(NASDAQ: IMDX) Delayed: 4.27 +0.14 (3.39%)
Previous Close $4.13    52 Week High
Open $4.13    52 Week Low
Day High $4.32    P/E N/A 
Day Low $3.85    EPS
Volume 212,818